W/E no (%) | ISC no (%) | Crude OR | MHOR (95% CI) | p value | |
---|---|---|---|---|---|
Men | n=154 | n=183 | |||
Asthma follow up by GP/nurse | 53 (34) | 59 (32) | 1.11 | 1.02 (0.61 to 1.69) | 0.956 |
Asthma follow up by hospital | 8 (5) | 28 (15) | 0.28 | 0.26 (0.09 to 0.78) | 0.012 |
Previous asthma admission | 44 (29) | 50 (27) | 1.06 | 0.97 (0.57 to 1.64) | 0.986 |
Previous A&E attendance only | 25 (16) | 22 (12) | 1.42 | 1.45 (0.73 to 2.90) | 0.333 |
Women | n=191 | n=161 | |||
Asthma follow up by GP/nurse | 62 (32) | 57 (35) | 0.88 | 0.89 (0.56 to 1.44) | 0.709 |
Asthma follow up by hospital | 10 (5) | 21 (13) | 0.36 | 0.36 (0.15 to 0.86) | 0.021 |
Previous asthma admission | 39 (20) | 64 (40) | 0.42 | 0.41 (0.24 to 0.67) | <0.001 |
Previous A&E attendance only | 32 (17) | 30 (19) | 0.87 | 0.91 (0.50 to 1.63) | 0.823 |
W/E = white European; ISC = Indian subcontinent; OR = odds ratio; MH = Mantel-Haenszel. CI = Cornfield 95% confidence intervals.
p values of <0.05 considered significant (MH χ2 test).